• 227
  • Comment
  • Favorite

BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity

Tiger Newspress2021-08-13

BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.

BioNTech was up 3% and Moderna gained 3%, while Pfizer , which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.

Late on Thursday, the U.S. Food and Drug Administration authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.

Pfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.

Going forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • ahoon
    ·2021-08-16
    ?
    Reply
    Report
  • Dave Fu
    ·2021-08-15
    Good 
    Reply
    Report
  • robot1234
    ·2021-08-15
    Analysts have estimated an annual sales at around $5 billion or higher for the booster shot. Congrats to retail investors holding these 2 counters. 
    Reply
    Report
  • KDaDa
    ·2021-08-15
    Stay safe by getting vaccinated & wearing your masks. Reduce infections & fatalities to return todaily norm.
    Reply
    Report
  • STKG
    ·2021-08-15
    Looking forward 
    Reply
    Report
  • jackytanks
    ·2021-08-14
    ?
    Reply
    Report
  • 21900VAHP
    ·2021-08-14
    mRNA vaccine champion. :)
    Reply
    Report
    Fold Replies
    • koolgal
      Me too??????
      2021-08-29
      Reply
      Report
  • June陈
    ·2021-08-14
    Good.
    Reply
    Report
  • carolinetsh
    ·2021-08-14
    Please like
    Reply
    Report
  • James1987
    ·2021-08-14
    Oh 
    Reply
    Report
  • GoldenEyes
    ·2021-08-14
    Good
    Reply
    Report
  • seojun
    ·2021-08-14
    Booster up!!!
    Reply
    Report
  • koolgal
    ·2021-08-14
    Moderna and Pfizer have tremendous growth ahead.  So let's get on the cash train! ???
    Reply
    Report
    Fold Replies
    • koolgal
      Tremendous potential.  The sky is the limit as long as Covid-19 is around. ??
      2021-08-14
      Reply
      Report
    • CPCat
      agree! very strong sentiments on what they can achieve in future
      2021-08-14
      Reply
      Report
  • akhwe
    ·2021-08-14
    Buy moderna then
    Reply
    Report
  • airmanbc
    ·2021-08-13
    Yes, we need a booster ?
    Reply
    Report
    Fold Replies
    • seojun
      yeah
      2021-08-14
      Reply
      Report
    • Investcub
      Agreed
      2021-08-13
      Reply
      Report
  • Jennifer58
    ·2021-08-13
    Go go gi
    Reply
    Report
    Fold Replies
  • LimHianYew
    ·2021-08-13
    [Cool] 
    Reply
    Report
  • rayydream
    ·2021-08-13
    Like pls
    Reply
    Report
    Fold Replies
    • LimHianYew
      Done, good luck
      2021-08-13
      Reply
      Report
  • RoarLionRoar
    ·2021-08-13
    Hmmm
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial